Ontario Health, based on guidance from the Ontario Health Technology Advisory Committee, is recommending publicly funding transcatheter valve-in-valve implantation for adults with degenerated mitral or tricuspid bioprosthetic valves who are considered inoperable or high-risk for surgery.
The provincial government agency is seeking feedback on its recommendation from healthcare stakeholders and the public by October 25, 2021.
Click here to share your feedback: https://www.hqontario.ca/Evidence-to-Improve-Care/Health-Technology-Assessment/Reviews-And-Recommendations/Transcatheter-Valve-in-Valve-Implantation-for-Degenerated-Mitral-or-Tricuspid-Bioprosthetic-Valves.
For more information, please contact the OAC office:
34 Eglinton Ave. West
Toronto, Ontario M4R 2H6
E-mail: [email protected]